SOLIUS Competitors and Similar CompaniesClear all

SOLIUS's competitors and similar companies include ReShape Lifesciences, ElectroCore and FIRE1.
SOLIUS
SOLIUS
SOLIUS (also known as Benesol) is a company that develops medical light therapy solutions.
ReShape Lifesciences
ReShape Lifesciences
ReShape Lifesciences, a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders.
ElectroCore
ElectroCore
ElectroCore develops neuromodulation therapies for the non-invasive treatment of diseases and disorders.
FIRE1
FIRE1
FIRE1 focuses on developing novel remote monitoring devices.
Founding Date
Founding Date
2011
Founding Date
2002
Founding Date
2005
Founding Date
N/A
Type
Type
Private
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Bainbridge Island, US HQ
Locations
San Clemente, US HQ
San Clemente, US
Locations
Rockaway, US HQ
Parksville, CA
Geretsried, DE
Hamburg, DE
Yeadon, GB
Bernards, US
Locations
Dublin, IE HQ
Dublin, IE
Employees
Employees
31
Employees
4348% decrease
Employees
5144% decrease
Employees
838% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
3 m
Valuation ($)
71.2 m
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$11.3m (FY, 2020)
Revenue (est.)
$32m (FY, 2025)
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
$5m (FY, 2020)
Cost of goods
$4.2m (FY, 2025)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
$6.3m (FY, 2020)
Gross profit
$27.8m (FY, 2025)
Gross profit
N/A
Net income
Net income
N/A
Net income
($21.6m) (FY, 2020)
Net income
($14m) (FY, 2025)
Net income
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 127m
Total funding raised
$ 7.5m
For sources of this data, please see the company profile

View Company Profiles

ReShape Lifesciences
HQ
San Clemente, US
Employees
43↓ 48% decrease

ReShape Lifesciences, a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders.

View company
ElectroCore
HQ
Rockaway, US
Employees
51↓ 44% decrease

ElectroCore develops neuromodulation therapies for the non-invasive treatment of diseases and disorders.

View company
FIRE1
HQ
Dublin, IE
Employees
83↑ 8% increase

FIRE1 focuses on developing novel remote monitoring devices.

View company